CN1314169A - Medicine for treating hepatitis B - Google Patents
Medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN1314169A CN1314169A CN00136250A CN00136250A CN1314169A CN 1314169 A CN1314169 A CN 1314169A CN 00136250 A CN00136250 A CN 00136250A CN 00136250 A CN00136250 A CN 00136250A CN 1314169 A CN1314169 A CN 1314169A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- kilograms
- herba
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine composite includes cimicifuga, tree peony bark, peach kernel, calcitum, Radix Ledebouriellae and other Chinese medicinal materials. It has a total effective rate on chronic hepatitis B as high as 100%.
Description
The present invention relates to a kind of medicine for the treatment of chronic hepatitis B, is to be the medicine of the treatment chronic hepatitis B made of raw material with the Chinese herbal medicine specifically.
Chronic hepatitis B is the very common disease of China, and 100,000,000 2 thousand ten thousand hepatitis b virus carriers are arranged approximately, wherein 10% develops into chronic hepatitis.Chronic hepatitis protracted course of disease, but part grievous injury liver function, even cause liver cirrhosis.
At present, the Drug therapy to chronic hepatitis B has run into following problems:
1, the doctor trained in Western medicine aspect mainly is to suppress virus replication, regulates immunity of organisms, and virus can't be discharged and virus is killed.Commonly used is interferon, but this medicine costs an arm and a leg, and the surface antigen negative conversion rate is about 30%.The life-time service hepatoprotective is easy to generate virus variation simultaneously, symptom bounce-back, and medical expense costliness, and cure rate is low.
2, traditional Chinese medical science aspect yet finds no the specific medicament of treatment primary disease.
Therefore, the object of the present invention is to provide and a kind ofly can remove virus in the body, make the medicine of the treatment chronic hepatitis B that Australia antigen turns out cloudy.
Solution of the present invention is based on secret prescription handed down in the family from generation to generation and motherland's Chinese medicine to pathogenetic understanding of chronic hepatitis B and Therapeutic Principle, simultaneously with reference to the modern medicine achievement, sums up through experience accumulation for many years.By the theory of Chinese medical science prescription, skim the cream off milk, make it give full play to drug effect.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Rhizoma Cimicifugae 8-12 Cortex Moutan 10-20 Semen Persicae 10-20
Mirabilitum crystallina 150-250 Radix Saposhnikoviae 8-12 Herba Selaginellae 10-20
Herba Ephedrae 8-12 Herba Artemisiae Scopariae 60-100 Radix Bupleuri 8-12
Flos Lonicerae 200-300 Fructus Forsythiae 150-190 Concha Haliotidis 30-70
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 8-12 Herba Dianthi 8-12 Semen Arecae 8-12
Radix Scrophulariae 30-70 70-110 Radix Ophiopogonis Radix Asparagi 70-110
Radix Scutellariae 10-20 Radix Trichosanthis 100-200 Radix Glycyrrhizae 8-12
Rhizoma Coptidis 15-25 Cortex Phellodendri 150-250 Fructus Gardeniae 10-20
Concha Ostreae 25-35 succinum 10-20 Radix Et Rhizoma Rhei 8-12
The big Fructus Jujubae 70-110 of Endoconcha Sepiae 15-25 Rhizoma Belamcandae 8-12
Optimum weight part proportioning of the present invention is:
Rhizoma Cimicifugae 10 Cortex Moutans 15 Semen Persicaes 15
Mirabilitum crystallina 200 Radix Saposhnikoviaes 10 Herba Selaginellaes 15
Herba Ephedrae 10 Herba Artemisiae Scopariae 80 Radix Bupleuri 10
Flos Lonicerae 250 Fructus Forsythiaes 170 Concha Haliotidis 50
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10 Herba Dianthis 10 Semen Arecaes 10
Radix Scrophulariae Radix Asparagi 90 50 Radix Ophiopogonis 90
Radix Scutellariae 15 Radix Trichosanthis 150 Radix Glycyrrhizaes 10
Rhizoma Coptidis 20 Cortex Phellodendris 200 Fructus Gardeniaes 15
Concha Ostreae 30 succinums 15 Radix Et Rhizoma Rhei 10
Endoconcha Sepiae 20 Rhizoma Belamcandae 10 big Fructus Jujubaes 90
Aforementioned pharmaceutical compositions of the present invention can be prepared into any pharmaceutical dosage form that is suitable for using clinically, powder for example, tablet, capsule, pill, oral liquid etc.
The production method that above-mentioned each component is made drug powder of the present invention is:
1, earlier that each component is dry respectively, be crushed to 120 order fine powders;
2, with the abundant mixing of above-mentioned each component fine powder;
3, mixed medicated powder is made every bag of powder that contains medicated powder 100 grams.
Medicine of the present invention is used for clinical practice, has obtained notable therapeutic effect.Facts have proved that medicine of the present invention is very effective for the treatment chronic hepatitis B.It below is summary to the clinical practice result.
The inventor has selected 300 routine patients, comprises chronic persistent hepatitis and chronic active hepatitis, and wherein 95% has abnormal liver function, and the male accounts for 45%, and the women accounts for 55%, adopts laboratory five indexes of hepatitis b regulating liver-QI functional diagnosis standard, is diagnosed as chronic hepatitis B.The Therapeutic Method of medicine of the present invention is 2 times on the one, is decocted in water for oral dose with 100 gram powders at every turn and takes for 2 times again.Three months is a course of treatment, three to four courses of treatment of general treatment.As a result, through the tracking in 10 years visit, 95 routine laboratory checking index (comprise surface antigen and e antigen turn out cloudy) are normal fully, reach 32%, and other has 181 routine liver function recoveries normal, and clinical symptoms such as appetite descend, and abdominal distention weakly waits disappearance, reaches 60%.All the other 24 routine clinical symptoms have improvement.And, do not find routine patient's recurrence.Therefore, total effective rate is 100%.
Therefore, the characteristics of medicine of the present invention are that production method is simple, and are with low cost, evident in efficacy, take effect fast, have no side effect.In addition, medicine of the present invention also has therapeutic effect to hepatitis B virus carriers.
The traditional Chinese medical science thinks that hepatitis mostly is depression of liver-QI, due to the noxious dampness heap soil or fertilizer over and around the roots stagnates.Depressed liver-energy dispersing and QI regulating, the method for heat-clearing and toxic substances removing damp eliminating are adopted in treatment.Pharmaceutical composition of the present invention has searched out the active drug compositions of treatment chronic hepatitis B based on this screening of medicaments.Medicine of the present invention has the body of keeping normal activity, checks Normocellular pathological changes, removes virocyte, promotes the reparation of normal tissue cell, supplement consumed, the old Cuo of the aster of dispelling, the effect of getting rid of evils and expelling the heat-evil.
Embodiment 1
15 kilograms in 15 kilograms of Semen Persicaes of 10 kilograms of Cortex Moutans of Rhizoma Cimicifugae
15 kilograms of 10 kilograms of Herba Selaginellaes of 200 kilograms of Radix Saposhnikoviaes of Mirabilitum crystallina
10 kilograms of 80 kilograms of Radix Bupleuri of 10 kilograms of Herba Artemisiae Scopariae of Herba Ephedrae
50 kilograms of 170 kilograms of Concha Haliotidis of 250 kilograms of Fructus Forsythiaes of Flos Lonicerae
10 kilograms of 10 kilograms of Semen Arecaes of 10 kilograms of Herba Dianthis of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)
90 kilograms of Radix Scrophulariae 90 kilograms of Radix Asparagis, 50 kilograms of Radix Ophiopogonis
10 kilograms in 150 kilograms of Radix Glycyrrhizaes of 15 kilograms of Radix Trichosanthis of Radix Scutellariae
15 kilograms of 200 kilograms of Fructus Gardeniaes of 20 kilograms of Cortex Phellodendris of Rhizoma Coptidis
10 kilograms of 15 kilograms of Radix Et Rhizoma Rhei of 30 kilograms of succinums of Concha Ostreae
90 kilograms of 10 kilograms big Fructus Jujubaes of 20 kilograms of Rhizoma Belamcandae of Endoconcha Sepiae
With above-mentioned medical material oven dry, be ground into fine powder, cross 120 mesh sieves; With the abundant mix homogeneously of fine powder; Mixed medicated powder is made every bag of powder that contains medicated powder 100 grams.
Embodiment 2
20 kilograms in 20 kilograms of Semen Persicaes of 12 kilograms of Cortex Moutans of Rhizoma Cimicifugae
20 kilograms of 12 kilograms of Herba Selaginellaes of 250 kilograms of Radix Saposhnikoviaes of Mirabilitum crystallina
12 kilograms of 12 kilograms of Herba Artemisiae Scopariae double centners of Herba Ephedrae Radix Bupleuri
70 kilograms of 190 kilograms of Concha Haliotidis of 300 kilograms of Fructus Forsythiaes of Flos Lonicerae
12 kilograms of 12 kilograms of Semen Arecaes of 12 kilograms of Herba Dianthis of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)
110 kilograms of Radix Scrophulariae 110 kilograms of Radix Asparagis, 70 kilograms of Radix Ophiopogonis
12 kilograms in 200 kilograms of Radix Glycyrrhizaes of 20 kilograms of Radix Trichosanthis of Radix Scutellariae
20 kilograms of 250 kilograms of Fructus Gardeniaes of 25 kilograms of Cortex Phellodendris of Rhizoma Coptidis
12 kilograms of 20 kilograms of Radix Et Rhizoma Rhei of 35 kilograms of succinums of Concha Ostreae
110 kilograms of 12 kilograms big Fructus Jujubaes of 25 kilograms of Rhizoma Belamcandae of Endoconcha Sepiae
Method for making is the same.
Embodiment 3
10 kilograms in 10 kilograms of Semen Persicaes of 8 kilograms of Cortex Moutans of Rhizoma Cimicifugae
10 kilograms of 8 kilograms of Herba Selaginellaes of 150 kilograms of Radix Saposhnikoviaes of Mirabilitum crystallina
8 kilograms of 60 kilograms of Radix Bupleuri of 8 kilograms of Herba Artemisiae Scopariae of Herba Ephedrae
30 kilograms of 150 kilograms of Concha Haliotidis of 200 kilograms of Fructus Forsythiaes of Flos Lonicerae
8 kilograms of 8 kilograms of Semen Arecaes of 8 kilograms of Herba Dianthis of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)
70 kilograms of Radix Scrophulariae 70 kilograms of Radix Asparagis, 30 kilograms of Radix Ophiopogonis
8 kilograms in 10 kilograms of Radix Trichosanthis double centners of Radix Scutellariae Radix Glycyrrhizae
10 kilograms of 150 kilograms of Fructus Gardeniaes of 15 kilograms of Cortex Phellodendris of Rhizoma Coptidis
8 kilograms of 10 kilograms of Radix Et Rhizoma Rhei of 25 kilograms of succinums of Concha Ostreae
70 kilograms of 8 kilograms big Fructus Jujubaes of 15 kilograms of Rhizoma Belamcandae of Endoconcha Sepiae
Method for making is with embodiment 1.
Claims (4)
1, a kind of pharmaceutical composition for the treatment of chronic hepatitis B is characterized in that forming and counts by weight:
Rhizoma Cimicifugae 8-12 Cortex Moutan 10-20 Semen Persicae 10-20
Mirabilitum crystallina 150-250 Radix Saposhnikoviae 8-12 Herba Selaginellae 10-20
Herba Ephedrae 8-12 Herba Artemisiae Scopariae 60-100 Radix Bupleuri 8-12
Flos Lonicerae 200-300 Fructus Forsythiae 150-190 Concha Haliotidis 30-70
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 8-12 Herba Dianthi 8-12 Semen Arecae 8-12
Radix Scrophulariae 30-70 70-110 Radix Ophiopogonis Radix Asparagi 70-110
Radix Scutellariae 10-20 Radix Trichosanthis 100-200 Radix Glycyrrhizae 8-12
Rhizoma Coptidis 15-25 Cortex Phellodendri 150-250 Fructus Gardeniae 10-20
Concha Ostreae 25-35 succinum 10-20 Radix Et Rhizoma Rhei 8-12
The big Fructus Jujubae 70-110 of Endoconcha Sepiae 15-25 Rhizoma Belamcandae 8-12
2,, it is characterized in that the weight proportion of each component is according to the pharmaceutical composition of claim 1:
Rhizoma Cimicifugae 10 Cortex Moutans 15 Semen Persicaes 15
Mirabilitum crystallina 200 Radix Saposhnikoviaes 10 Herba Selaginellaes 15
Herba Ephedrae 10 Herba Artemisiae Scopariae 80 Radix Bupleuri 10
Flos Lonicerae 250 Fructus Forsythiaes 170 Concha Haliotidis 50
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10 Herba Dianthis 10 Semen Arecaes 10
Radix Scrophulariae Radix Asparagi 90 50 Radix Ophiopogonis 90
Radix Scutellariae 15 Radix Trichosanthis 150 Radix Glycyrrhizaes 10
Rhizoma Coptidis 20 Cortex Phellodendris 200 Fructus Gardeniaes 15
Concha Ostreae 30 succinums 15 Radix Et Rhizoma Rhei 10
Endoconcha Sepiae 20 Rhizoma Belamcandae 10 big Fructus Jujubaes 90
3, according to the pharmaceutical composition of claim 1, the dosage form that it is characterized in that this medicine is a said dosage form on any pharmaceutics.
4, according to the pharmaceutical composition of claim 1, the dosage form that it is characterized in that this pharmaceutical composition is a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00136250A CN1116890C (en) | 2000-12-26 | 2000-12-26 | Medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00136250A CN1116890C (en) | 2000-12-26 | 2000-12-26 | Medicine for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1314169A true CN1314169A (en) | 2001-09-26 |
| CN1116890C CN1116890C (en) | 2003-08-06 |
Family
ID=4597168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00136250A Expired - Fee Related CN1116890C (en) | 2000-12-26 | 2000-12-26 | Medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1116890C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100408064C (en) * | 2005-05-30 | 2008-08-06 | 许建文 | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine |
| CN101785804A (en) * | 2010-04-22 | 2010-07-28 | 通化金马药业集团股份有限公司 | Liver-cleansing yellow-removing medicament |
| CN102526473A (en) * | 2012-03-21 | 2012-07-04 | 张蓉 | Medicament for treating chronic virus B hepatitis |
| CN103191386A (en) * | 2013-03-22 | 2013-07-10 | 岳伟真 | Medicament for treating chronic hepatitis B |
-
2000
- 2000-12-26 CN CN00136250A patent/CN1116890C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100408064C (en) * | 2005-05-30 | 2008-08-06 | 许建文 | Prepn process of medicine for treating icteric diseases and oral liquid containing the medicine |
| CN101785804A (en) * | 2010-04-22 | 2010-07-28 | 通化金马药业集团股份有限公司 | Liver-cleansing yellow-removing medicament |
| CN101785804B (en) * | 2010-04-22 | 2011-05-25 | 通化金马药业集团股份有限公司 | Acute icteric viral hepatitis medicament |
| CN102526473A (en) * | 2012-03-21 | 2012-07-04 | 张蓉 | Medicament for treating chronic virus B hepatitis |
| CN103191386A (en) * | 2013-03-22 | 2013-07-10 | 岳伟真 | Medicament for treating chronic hepatitis B |
| CN103191386B (en) * | 2013-03-22 | 2014-04-30 | 刘晓燕 | Medicament for treating chronic hepatitis B |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1116890C (en) | 2003-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1907462A (en) | Traditional Chinese medicine composition for treating hepatitis and fatty liver | |
| CN1876074A (en) | A constipation-treating medicament and preparation method thereof | |
| CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
| CN1293898C (en) | Medicine composition for treating viral hepatitis and its preparation method | |
| CN1116890C (en) | Medicine for treating hepatitis B | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN100340286C (en) | Medicine for treating hepatitis B and its preparing method | |
| CN1168488C (en) | Chinese medicinal preparation for treating pyretic stranguria | |
| CN1709288A (en) | Medicinal composition, and its preparing method and use | |
| CN1857684A (en) | Compound Chinese medicine preparation for removing toxic matter, dispersing blood clots and strengthing body's resistance and its preparaing process | |
| CN1772270A (en) | Tiantan prepn for treating kidney-yang deficiency diseases and its production process | |
| CN100342888C (en) | Chinese medicine preparation for treating prostatic hyperplasia | |
| CN1059104C (en) | Capsule for anti hepatitis B | |
| CN1130212C (en) | Medicine for treating abdominal node and its preparing process | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN1679887A (en) | Chinese medicine composition for treating hepatitis | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1438027A (en) | Chinese medicine for treating breast disease | |
| CN1475261A (en) | Medicine for treating gastral cavity pain and its preparation method | |
| CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
| CN1275640C (en) | Medicine for treating chromic avidity, persistent hepatitis B and its preparation method | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030806 Termination date: 20100126 |